Načítá se...
Does heterogeneity matter in the estimation of tumour budding and tumour stroma ratio in colon cancer?
BACKGROUND: Tumour budding (TB) and Tumour Stroma Ratio (TSR) may be rewarding in the treatment stratification of patients with stage II colon cancer. However, lack of standardization may exclude these parameters from being used in a clinical setting. The purpose of this methodologic study was to co...
Uloženo v:
| Vydáno v: | Diagn Pathol |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5859415/ https://ncbi.nlm.nih.gov/pubmed/29558947 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13000-018-0697-9 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|